$CKX
CKX Lands Inc

2024 Q3 Form 10-Q Financial Statement

#000143774924026102 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $171.3K $1.027M
YoY Change -33.88% 177.4%
Cost Of Revenue $17.71K
YoY Change 33.96%
Gross Profit $1.010M
YoY Change 182.71%
Gross Profit Margin 98.28%
Selling, General & Admin $503.1K
YoY Change 98.09%
% of Gross Profit 49.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.065K $1.065K
YoY Change 0.0% 0.0%
% of Gross Profit 0.11%
Operating Expenses $504.2K
YoY Change 97.67%
Operating Profit -$16.93K $646.1K
YoY Change -544.01% 532.83%
Interest Expense $50.88K
YoY Change 43.16%
% of Operating Profit 7.87%
Other Income/Expense, Net $13.75K
YoY Change
Pretax Income $37.21K $710.8K
YoY Change -21.91% 416.4%
Income Tax -$16.91K $145.5K
% Of Pretax Income -45.45% 20.47%
Net Earnings $54.12K $565.3K
YoY Change 51.45% 447.6%
Net Earnings / Revenue 31.6% 55.02%
Basic Earnings Per Share $0.03 $0.28
Diluted Earnings Per Share $0.03 $0.27
COMMON SHARES
Basic Shares Outstanding 2.027M 2.027M
Diluted Shares Outstanding 2.064M 2.063M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.393M
YoY Change 12.01%
Cash & Equivalents $3.319M $7.867M
Short-Term Investments $1.527M
Other Short-Term Assets $125.8K
YoY Change 4.29%
Inventory
Prepaid Expenses
Receivables $84.80K $136.6K
Other Receivables $32.61K
Total Short-Term Assets $9.461M $9.688M
YoY Change 8.17% 12.79%
LONG-TERM ASSETS
Property, Plant & Equipment $9.092M $9.093M
YoY Change -0.05% -0.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $168.7K
YoY Change -51.08%
Total Long-Term Assets $9.264M $9.262M
YoY Change -1.75% -1.92%
TOTAL ASSETS
Total Short-Term Assets $9.461M $9.688M
Total Long-Term Assets $9.264M $9.262M
Total Assets $18.73M $18.95M
YoY Change 3.02% 5.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $219.8K
YoY Change 875.89%
Accrued Expenses
YoY Change
Deferred Revenue $122.5K $95.11K
YoY Change 29.22% 1.67%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $174.1K $466.3K
YoY Change 47.49% 301.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $174.1K $466.3K
Total Long-Term Liabilities $0.00
Total Liabilities $174.1K $466.3K
YoY Change 47.49% 301.73%
SHAREHOLDERS EQUITY
Retained Earnings $15.59M $15.54M
YoY Change 3.04% 2.92%
Common Stock $59.34K $59.34K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.55M $18.48M
YoY Change
Total Liabilities & Shareholders Equity $18.73M $18.95M
YoY Change 3.02% 5.09%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $54.12K $565.3K
YoY Change 51.45% 447.6%
Depreciation, Depletion And Amortization $1.065K $1.065K
YoY Change 0.0% 0.0%
Cash From Operating Activities $691.8K
YoY Change 255.51%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $140.6K
YoY Change -86.01%
Cash From Investing Activities $140.6K
YoY Change -85.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -208.9K
YoY Change
NET CHANGE
Cash From Operating Activities 691.8K
Cash From Investing Activities 140.6K
Cash From Financing Activities -208.9K
Net Change In Cash 623.5K
YoY Change -47.86%
FREE CASH FLOW
Cash From Operating Activities $691.8K
Capital Expenditures $0.00
Free Cash Flow $691.8K
YoY Change 261.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
324368 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160419 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
103228 usd
us-gaap Net Income Loss
NetIncomeLoss
163949 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
103228 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17916832 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-29061 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
353909 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
125787 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
212279 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9388882 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9095403 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
901294 usd
CY2023Q2 us-gaap Revenues
Revenues
370380 usd
us-gaap Revenues
Revenues
1169283 usd
us-gaap Revenues
Revenues
536142 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
253991 usd
CY2023Q2 us-gaap Depreciation
Depreciation
1065 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-140582 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-149992 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
268278 usd
us-gaap Costs And Expenses
CostsAndExpenses
959761 usd
us-gaap Costs And Expenses
CostsAndExpenses
776849 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
102102 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
209522 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-240707 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
101099 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
61493 usd
CY2023Q2 ckx Miscellaneous Income
MiscellaneousIncome
0 usd
ckx Miscellaneous Income
MiscellaneousIncome
13747 usd
ckx Miscellaneous Income
MiscellaneousIncome
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
137637 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-179214 usd
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q2 us-gaap Assets Current
AssetsCurrent
9688496 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9093252 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
168702 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
329121 usd
CY2024Q2 us-gaap Assets
Assets
18950450 usd
CY2023Q4 us-gaap Assets
Assets
18813406 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159159 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
95111 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
466287 usd
CY2024Q2 us-gaap Liabilities
Liabilities
466287 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2066044
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2027032
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
59335 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3361386 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39012
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18484163 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18950450 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105505 usd
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
472602 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15536044 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000352955
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
32609 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219772 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
151404 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
151404 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
184785 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
495348 usd
CY2023Q4 us-gaap Liabilities
Liabilities
495348 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2014283
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1991337
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
59335 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3150376 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
22946
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
263748 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15372095 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18318058 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18813406 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1066159 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
35535 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
34409 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
160419 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-44803 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34409 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-44803 usd
us-gaap Net Income Loss
NetIncomeLoss
-134411 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1974427
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2009185
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1974427
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2036560
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2045539
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1974427
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
18022234 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
208854 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
565278 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18484163 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
17709245 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104359 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18318058 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
211010 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
208854 usd
us-gaap Net Income Loss
NetIncomeLoss
163949 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18484163 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17420414 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
630829 usd
us-gaap Net Income Loss
NetIncomeLoss
-134411 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17916832 usd
us-gaap Net Income Loss
NetIncomeLoss
163949 usd
us-gaap Net Income Loss
NetIncomeLoss
-134411 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Depletion
Depletion
21 usd
us-gaap Depletion
Depletion
85 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
160419 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-44803 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
140582 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
149992 usd
us-gaap Share Based Compensation
ShareBasedCompensation
211010 usd
us-gaap Share Based Compensation
ShareBasedCompensation
630829 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
13977 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
48546 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-151107 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104185 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1500000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1534485 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1004603 usd
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
-0 usd
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
20735 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
140582 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
149992 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
175067 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1133860 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
208854 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-208854 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
320122 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1238045 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7546689 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7148207 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7866811 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8386252 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash balances in nine financial institutions. At times, cash balances may exceed the Federal Deposit Insurance Corporation’s insured limit of $250,000. The Company has not experienced any losses in such accounts and management believes the Company is not exposed to any significant credit risk on its cash balances.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310794
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9187180 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9187200 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93928 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91797 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9093252 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9095403 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
140582 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
149992 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Depreciation
Depreciation
2130 usd
us-gaap Depletion
Depletion
21 usd
us-gaap Depletion
Depletion
85 usd
CY2023Q4 ckx Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedNumber
71788
CY2024Q2 ckx Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedNumber
123549

Files In Submission

Name View Source Status
0001437749-24-026102-index-headers.html Edgar Link pending
0001437749-24-026102-index.html Edgar Link pending
0001437749-24-026102.txt Edgar Link pending
0001437749-24-026102-xbrl.zip Edgar Link pending
ckx-20240630.xsd Edgar Link pending
ckx20240630_10q.htm Edgar Link pending
ex_709706.htm Edgar Link pending
ex_709707.htm Edgar Link pending
ex_709708.htm Edgar Link pending
ex_709710.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ckx-20240630_cal.xml Edgar Link unprocessable
ckx-20240630_def.xml Edgar Link unprocessable
ckx-20240630_lab.xml Edgar Link unprocessable
ckx-20240630_pre.xml Edgar Link unprocessable
ckx20240630_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable